Carcinoma exhibiting epithelial-mesenchymal transition manifests an M2 macrophage-enriched tumor immune microenvironment

We profiled genes relevant to the tumor-immune interface,in six metaplastic breast carcinomas (MpBCs). We profiled genes relevant to the tumor-immune interface, in invasive carcinoma of no special type (NST) [also called IDC] and its paired spindle carcinomatous (SPS) component, which is considered the EMT counterpart of the former, across six metaplastic breast carcinomas (MpBCs).